Skip to main content
XERS logo

XERS · Xeris Biopharma Holdings, Inc.

Track XERS — free
$8.60 +0.27 (+3.24%) At close · Aug 14
Market Cap
$1.57B
Shares
182.32M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-08-12 STEVEN PIEPER 20,000
2026-07-07 STEVEN PIEPER 27,600
2026-07-06 STEVEN PIEPER 17,400
2026-07-01 BETH HECHT 49,998
2026-07-01 KEVIN MCCULLOCH 120,000
2026-06-04 JOHN H JOHNSON 15,000
2026-06-04 DAWN HALKUFF 20,000
2026-06-04 Barbara-Jean Bormann-Kennedy 16,000
2026-06-03 MARLA PERSKY 15,500
2026-03-30 JAMES BRADY 10,834
2026-03-02 BETH HECHT 66,668
2026-01-08 KEVIN MCCULLOCH 60,000
2025-12-19 JOHN H JOHNSON 135,402
2025-12-12 BARBARA-JEAN A BORMANN-KENNEDY 15,000
2025-11-13 JOHN SHANNON 48,149
2025-11-12 BETH HECHT 66,668
2025-09-11 MARLA PERSKY 15,500
2025-08-28 JEFFREY SHERMAN 42,232
2025-08-13 JOHN H JOHNSON 107,500
2025-08-12 DAWN HALKUFF 42,500
2025-05-09 Fairley Ricki Louise 56,667
2025-03-20 Hecht Beth 40,000
Showing 1–22 of 22 filings
Key facts CIK 1867096 CUSIP 98422E103 13F (30d) 231 filings 226 filers Visit website Investor relations